Skip to main content
FinSpry Logo
FinSpry
IBRX logo
IBRX
(NASDAQ)
ImmunityBio, Inc.
$7.40-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ImmunityBio (IBRX) Stock Price & Financial Analysis

ImmunityBio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.33 - $7.57
52-Week High$12.43
52-Week Low$1.95
Open$7.36
Volume6.07M
Average Volume (3M)11.87M
Market Cap7.71B
Shares Outstanding1.03B
Price to Sales (P/S)54.27
Price to Book (P/B)-8.79
EV/EBITDA-11.80
Revenue (TTM)140.98M
Net Income (TTM)-854.53M
Free Cash Flow (TTM)-298.90M
EPS (TTM)$-0.89
Profit Margin-606.15%
Operating Margin-185.41%
50-Day MA$7.84
200-Day MA$5.68
52-Week Change163.25%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ImmunityBio

What is the current stock price for IBRX?

As of the latest trading session, IBRX stock trades at $7.40. The 52-week range is $1.95–$12.43, with a day range of $7.33–$7.57.

What is the P/E ratio for IBRX?

The P/E ratio (Price-to-Earnings) for IBRX is shown in the Key Statistics section. This valuation metric helps compare ImmunityBio, Inc. to industry peers.

Does IBRX pay dividends?

ImmunityBio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IBRX?

Based on 2 analysts, the consensus for IBRX is Buy.

What is the market cap of IBRX?

ImmunityBio's market capitalization is $7.60B, classifying it as a mid-cap company. ImmunityBio operates in the Healthcare sector within the Biotechnology industry.